Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
•
Neuro-Oncology
•
Medical Oncology
•
CNS Disease
•
Drug Toxicity
Is it safe to give large fraction stereotactic irradiation for brain metastases concurrently with VEGF inhibitors?
Related Questions
What are your top takeaways in Neuro Oncology from ASCO 2025?
What is the optimal management of pain and loss of function due to pathologic compression fractures?
How do you counsel glioblastoma multiforme patients on which types of clinical trials to pursue?
Would you consider adding gabapentin off label for use in the treatment of glioblastoma at this time?
In light of Aizer et al. data presented at ASCO 2025, what is your threshold for offering SRS/SRT in patients with multiple brain metastases?
How would you advise a younger patient with residual/recurrent optic nerve meningioma, proceeding with radiotherapy, about the risks of malignant transformation or induction of other brain malignancies because of radiation?
How would you treat an unresectable epithelioid angiosarcoma invading the cavernous sinus, wrapping around the carotid artery?
How would you manage an enlarging brain metastasis that has progressed in size three months after radiosurgery?
How do you manage follow up for patient who was diagnosed with pineal gland germinomas with drop metastatic to the spinal cord?
What are the best radiation therapy options for a young adult with 3 brain metastases from myeloid sarcoma that hasn’t responded well to intrathecal therapy?
